Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)

Hematologic Profile in Patients with Nasopharyngeal Carcinoma

Authors
Susilawati Susilawati1, *, Hamsu Kadriyan2, Wayan Putu Sutirtayasa3
1Department of ENT-HNS Praya Hospital, West Nusa Tenggara
2Department of ENT-HNS Medical Faculty Mataram University / Provinsi Hospital West Nusa Tenggara
3Medical Faculty Udayana University
*Corresponding author. Email: susilawatiketut88@gmail.com
Corresponding Author
Susilawati Susilawati
Available Online 21 February 2022.
DOI
10.2991/ahsr.k.220206.023How to use a DOI?
Keywords
Nasopharyngeal Carcinoma; Stage; Hematological Disorders
Abstract

Nasopharyngeal carcinoma (NPC) patients who are undergoing chemoradiotherapy, it is important to have a hematological profile examination to see hemoglobin and erythrocyte levels, the incidence of infection that has an effect on leukocyte levels and the risk of bleeding arising from a decrease in platelet levels. hematopoietic system. This study is a descriptive study using data from medical records of nasopharyngeal cancer patients at the NTB Provincial Hospital for the period January 2019 to December 2020. The data collected included patient identity, diagnosis, hemoglobin levels, erythrocyte index, leukocytes and platelets. Nasopharyngeal cancer is established through anamnesis, physical examination, histopathology and radiological investigations. Routine hematological examination is important in NPC patients to determine the presence of hematological abnormalities. Generally, the higher the NPC stage, the more complete the haematological abnormality will be. The incidence of anemia is related to the continuation of therapy and the patient’s quality of life. Leukocytosis is associated with the more progressive cancer; this leukocytosis will also increase platelet cells and cancer cells themselves. Thrombocytosis can be associated with advanced stage or metastases and a poor prognosis in NPC. Leukopenia can cause a decrease in the immune system so that patients are susceptible to infections, both bacterial and viral. Thrombocytopenia can increase the risk of bleeding.

Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

Volume Title
Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
Series
Advances in Health Sciences Research
Publication Date
21 February 2022
ISBN
10.2991/ahsr.k.220206.023
ISSN
2468-5739
DOI
10.2991/ahsr.k.220206.023How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

TY  - CONF
AU  - Susilawati Susilawati
AU  - Hamsu Kadriyan
AU  - Wayan Putu Sutirtayasa
PY  - 2022
DA  - 2022/02/21
TI  - Hematologic Profile in Patients with Nasopharyngeal Carcinoma
BT  - Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
PB  - Atlantis Press
SP  - 110
EP  - 115
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.220206.023
DO  - 10.2991/ahsr.k.220206.023
ID  - Susilawati2022
ER  -